2,561 results match your criteria: "Hospital Universitario "Lozano Blesa"[Affiliation]"
Alzheimers Dement (Amst)
October 2024
Departamento de Medicina, Psiquiatría y Dermatología, Facultad de Medicina Universidad de Zaragoza Zaragoza Spain.
Actas Dermosifiliogr
January 2025
Unidad de Investigación, Fundación Piel Sana AEDV, Madrid, Spain.
Blood Adv
January 2025
Grupo Español de Síndromes Mielodisplásicos, Madrid, Spain.
Neurol Ther
October 2024
Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Background: Limited information is available on patients' experience living with Huntington's disease (HD). The primary objective of this study was to assess the health-related quality of life and well being of patients with HD.
Methods: A non-interventional, cross-sectional study was conducted in 17 hospitals-based movement disorders units in Spain.
Public Health
December 2024
Research Unit, Hospital Clínico Universitario Lozano Blesa, Avda, San Juan Bosco, 15, 50009, Zaragoza, Spain; GIIS081-Research Group in nursing care, Sector III Zaragoza, Spain. Electronic address:
Objectives: This study sought to validate the HLS-Q12 in Spain and in the Spanish language, as well as describe the sociodemographic profile and the general health literacy of the study population.
Study Design: Descriptive cross-sectional.
Methods: Factor analysis and Cronbach's alpha were used to validate the Spanish version of the HLS-Q12.
Eur J Pediatr
December 2024
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168, Rome, Italy.
J Clin Oncol
October 2024
Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Rev Fac Cien Med Univ Nac Cordoba
September 2024
Hospital Clinico Universitario Lozano Blesa. Zaragoza. España.
Biomedicines
September 2024
Department of Big Data and Cognitive Systems, Instituto Tecnológico de Aragón, ITA, María de Luna 7-8, 50018 Zaragoza, Spain.
Background/objective: Gastric cancer (GC) is a complex disease representing a significant global health concern. Advanced tools for the early diagnosis and prediction of adverse outcomes are crucial. In this context, artificial intelligence (AI) plays a fundamental role.
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
November 2024
Policlínica Gipuzkoa.
Eur J Gastroenterol Hepatol
January 2025
Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain.
Introduction And Objectives: We report the results of the 2023 Spanish catheter ablation registry.
Methods: Procedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form.
Results: There were 104 participating centers in 2023 compared with 103 in 2022.
Epidemiologia (Basel)
September 2024
Faculty of Medicine, University of Zaragoza, 50009 Zaragoza, Aragón, Spain.
The definition of mental disorders has been traditionally a matter of discussion, and it has relevant implications in research and healthcare. Our aim was to explore the conceptualization medical students have of depression and to determine differences across academic years. The Maudsley Attitudes Questionnaire was adapted through a double translation, double back-translation and a preliminary validation, obtaining a Spanish edition.
View Article and Find Full Text PDFNurs Rep
September 2024
Instituto de Investigación Sanitaria de Aragón, 50009 Zaragoza, Spain.
The healthcare environment faced by nurses is complex, with high workloads and situations of high comorbidity. The integration of nurses into the work environment is a cause for concern, and improvements are sought for their incorporation into the workforce. The benefits of mentoring programs are described not only for nurses but also for patients with safer practices and benefits for the institution due to the increased commitment of its professionals.
View Article and Find Full Text PDFLancet Gastroenterol Hepatol
November 2024
IBD Unit, Hospital Clínico Universitario Lozano Blesa, Facultad de Medicina de Zaragoza, IIS Aragón, CIBEREHD, Zaragoza 50009, Spain. Electronic address:
Rev Esp Enferm Dig
September 2024
Aparato Digestivo, Hospital Clinico Universitario Lozano Blesa, España.
Rev Esp Enferm Dig
September 2024
Aparato Digestivo, Hospital Clinico Universitario Lozano Blesa, España.
We present the case of a 57-year-old woman with metastatic colorectal cancer being treated with Bevacizumab and FOLFOX, who came to the emergency department with haematemesis. Gastroscopy showed a duodenal ulcer without active bleeding. Subsequently, he suffered haemodynamic instability and an Angio-CT scan revealed an aortoenteric fistula, requiring urgent surgery.
View Article and Find Full Text PDFBlood
December 2024
Hematology Department, IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario de Salamanca, Salamanca, Spain.
Quantitative immunoprecipitation mass spectrometry (QIP-MS) allows the identification of the M-protein in patients with multiple myeloma (MM) otherwise in complete response, and could be considered suitable for measurable residual disease (MRD) evaluation in peripheral blood. In the context of the GEM2012MENOS65 and GEM2014MAIN trials, we compared the performance of QIP-MS in serum with next-generation flow (NGF) cytometry in bone marrow to assess MRD in paired samples obtained postinduction, transplant, consolidation and after 24 cycles of maintenance. At each time point, both NGF and QIP-MS were able to segregate 2 groups of patients with significantly different progression-free survival; when the evolution of the results obtained with either method was considered, maintaining or converting to MRD negativity was associated with longer survival, significantly better when compared with sustaining or converting to MRD positivity.
View Article and Find Full Text PDFAliment Pharmacol Ther
November 2024
Gastrointestinal Units of Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Clin Cancer Res
November 2024
MeCo Diagnostics, San Diego, California.
Rev Esp Enferm Dig
December 2024
Hepatología y Trasplante Hepático, Hospital Universitario Reina Sofía. IMIBIC. CIBERehd, España.
Clin Transl Oncol
September 2024
Complejo Hospitalario Universitario de Albacete, C. Hermanos Falco, 37, 02006, Albacete, Spain.
Introduction: The lung immune prognostic index (LIPI) is a biomarker that combines the lactate dehydrogenase (LDH) value and the derived neutrophil/lymphocyte ratio (dNLR). Its prognostic ability has been reported in non-small cell lung cancer (NSCLC) with immunotherapy. In the context of extensive-stage small cell lung cancer (ES-SCLC) with chemoimmunotherapy, its role remains to be determined.
View Article and Find Full Text PDFCardiorenal Med
October 2024
Centro de Investigación Biomédica en Red (CIBER Cardiovascular), Madrid, Spain.
Introduction: A comprehensive assessment of congestion, including circulating biomarkers, is recommended in patients with acute heart failure. The circulating biomarkers natriuretic peptides (NPs) and carbohydrate antigen-125 (CA125) could be useful for congestion assessment in ambulatory chronic heart failure (CHF), but there is only limited information about their applicability in this context. Therefore, this study aimed to examine the association of plasma CA125 and NP levels with clinical and ultrasound congestion parameters in CHF.
View Article and Find Full Text PDFEmergencias
June 2024
Servicio de Urgencias, Hospital Universitario Miguel Servet, Zaragoza, España.
Liver Int
December 2024
Hepatology, Hepatobiliopancreatic Surgery and Transplant Laboratory, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) recurrence after liver transplantation (LT) seems unavoidable and gradual. We aimed to evaluate the diagnostic accuracy in the post-LT setting of patients transplanted for metabolic dysfunction-associated steatohepatitis (MASH) of recurrent hepatic steatosis and fibrosis identified with FibroScan, compared to biopsy findings.
Methods: This prospective cohort study included adults transplanted for MASH between 2010 and 2022 in three LT centres in Spain who underwent FibroScan and biopsy at least 1-year after LT.